Skip to main content

Vancomycin cerebrospinal fluid pharmacokinetics in children with cerebral ventricular shunt infections.

Publication ,  Journal Article
Autmizguine, J; Moran, C; Gonzalez, D; Capparelli, EV; Smith, PB; Grant, GA; Benjamin, DK; Cohen-Wolkowiez, M; Watt, KM
Published in: Pediatr Infect Dis J
October 2014

This study described the cerebrospinal fluid (CSF) exposure of vancomycin in 8 children prescribed intravenous vancomycin therapy for cerebral ventricular shunt infection. Vancomycin CSF concentrations ranged from 0.06 to 9.13 mg/L and the CSF: plasma ratio ranged from 0 to 0.66. Two of 3 children with a staphylococcal CSF infection had CSF concentrations greater than minimal inhibitory concentration at the end of the dosing interval.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Pediatr Infect Dis J

DOI

EISSN

1532-0987

Publication Date

October 2014

Volume

33

Issue

10

Start / End Page

e270 / e272

Location

United States

Related Subject Headings

  • Vancomycin
  • Prospective Studies
  • Pediatrics
  • Meningitis, Bacterial
  • Male
  • Infant
  • Humans
  • Female
  • Child, Preschool
  • Child
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Autmizguine, J., Moran, C., Gonzalez, D., Capparelli, E. V., Smith, P. B., Grant, G. A., … Watt, K. M. (2014). Vancomycin cerebrospinal fluid pharmacokinetics in children with cerebral ventricular shunt infections. Pediatr Infect Dis J, 33(10), e270–e272. https://doi.org/10.1097/INF.0000000000000385
Autmizguine, Julie, Cassie Moran, Daniel Gonzalez, Edmund V. Capparelli, P Brian Smith, Gerald A. Grant, Daniel K. Benjamin, Michael Cohen-Wolkowiez, and Kevin M. Watt. “Vancomycin cerebrospinal fluid pharmacokinetics in children with cerebral ventricular shunt infections.Pediatr Infect Dis J 33, no. 10 (October 2014): e270–72. https://doi.org/10.1097/INF.0000000000000385.
Autmizguine J, Moran C, Gonzalez D, Capparelli EV, Smith PB, Grant GA, et al. Vancomycin cerebrospinal fluid pharmacokinetics in children with cerebral ventricular shunt infections. Pediatr Infect Dis J. 2014 Oct;33(10):e270–2.
Autmizguine, Julie, et al. “Vancomycin cerebrospinal fluid pharmacokinetics in children with cerebral ventricular shunt infections.Pediatr Infect Dis J, vol. 33, no. 10, Oct. 2014, pp. e270–72. Pubmed, doi:10.1097/INF.0000000000000385.
Autmizguine J, Moran C, Gonzalez D, Capparelli EV, Smith PB, Grant GA, Benjamin DK, Cohen-Wolkowiez M, Watt KM. Vancomycin cerebrospinal fluid pharmacokinetics in children with cerebral ventricular shunt infections. Pediatr Infect Dis J. 2014 Oct;33(10):e270–e272.

Published In

Pediatr Infect Dis J

DOI

EISSN

1532-0987

Publication Date

October 2014

Volume

33

Issue

10

Start / End Page

e270 / e272

Location

United States

Related Subject Headings

  • Vancomycin
  • Prospective Studies
  • Pediatrics
  • Meningitis, Bacterial
  • Male
  • Infant
  • Humans
  • Female
  • Child, Preschool
  • Child